Phase 3 Study of Sofosbuvir and Ribavirin
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Phase 3 Study of Sofosbuvir and Ribavirin is a clinical trial[1].
Key Facts
- Phase 3 Study of Sofosbuvir and Ribavirin is located in Puerto Rico[2].
- Phase 3 Study of Sofosbuvir and Ribavirin is in the country of Australia[3].
- Phase 3 Study of Sofosbuvir and Ribavirin is in the country of Canada[4].
- Phase 3 Study of Sofosbuvir and Ribavirin is in the country of Italy[5].
- Phase 3 Study of Sofosbuvir and Ribavirin is in the country of Netherlands[6].
- Phase 3 Study of Sofosbuvir and Ribavirin is in the country of New Zealand[7].
- Phase 3 Study of Sofosbuvir and Ribavirin is in the country of Sweden[8].
- Phase 3 Study of Sofosbuvir and Ribavirin's instance of is recorded as clinical trial[9].
- Phase 3 Study of Sofosbuvir and Ribavirin's start time is recorded as +2011-12-31T00:00:00Z[10].
- Phase 3 Study of Sofosbuvir and Ribavirin's end time is recorded as +2013-01-31T00:00:00Z[11].
- Phase 3 Study of Sofosbuvir and Ribavirin's sponsor is recorded as Gilead Sciences[12].
- Phase 3 Study of Sofosbuvir and Ribavirin's main subject is recorded as hepatitis C[13].
- Phase 3 Study of Sofosbuvir and Ribavirin's number of participants is recorded as {'unit': '1', 'amount': '+527'}[14].
- Phase 3 Study of Sofosbuvir and Ribavirin's title is recorded as A Phase 3, Multicenter, Randomized, Active-Controlled Study to Investigate the Safety and Efficacy of PSI-7977 and Ribavirin for 12 Weeks Compared to Pegylated Interferon and Ribavirin for 24 Weeks in Treatment-Naïve Patients With Chronic Genotype 2 or 3 HCV Infection[15].
- Phase 3 Study of Sofosbuvir and Ribavirin's short name is recorded as FISSION[16].
- Phase 3 Study of Sofosbuvir and Ribavirin's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[17].
- Phase 3 Study of Sofosbuvir and Ribavirin's ClinicalTrials.gov ID is recorded as NCT01497366[18].
- Phase 3 Study of Sofosbuvir and Ribavirin's research intervention is recorded as ribavirin[19].
- Phase 3 Study of Sofosbuvir and Ribavirin's research intervention is recorded as sofosbuvir[20].
- Phase 3 Study of Sofosbuvir and Ribavirin's clinical trial phase is recorded as phase III clinical trial[21].
- Phase 3 Study of Sofosbuvir and Ribavirin's research site is recorded as Mount Sinai Hospital[22].
- Phase 3 Study of Sofosbuvir and Ribavirin's research site is recorded as University of Alabama at Birmingham[23].
- Phase 3 Study of Sofosbuvir and Ribavirin's research site is recorded as Arrowhead Regional Medical Center[24].
- Phase 3 Study of Sofosbuvir and Ribavirin's research site is recorded as Atlanta Gastroenterology Associates[25].
- Phase 3 Study of Sofosbuvir and Ribavirin's research site is recorded as Beth Israel Deaconess Medical Center[26].